Jaffer Ajani (@jafferajanimd) Twitter Tweets • TwiCopy

Jaffer Ajani

@jafferajanimd

+ Follow

Professor, Department of Gastrointestinal Medical Oncology of MDACC, Chair of Gastric cancer and Esophageal cancer Panels of the NCCN

ID: 1534306038198960129

calendar_today07-06-2022 22:47:27

2 Tweet

96 Followers

62 Following

Gate.io

@gate_io

5 hours ago

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

thumb_up_off_alt34

chat_bubble_outline39

repeat6

shareShare

The U.S. FDA has approved two immunotherapy combinations for patients with advanced or metastatic esophageal cancer for whom surgery isn’t an option. Our Dr. Jaffer Ajani co-led the clinical trial, which led to the practice-changing approval: bit.ly/3a50l1W #EndCancer

The <a href="/US_FDA/">U.S. FDA</a> has approved two immunotherapy combinations for patients with advanced or metastatic esophageal cancer for whom surgery isn’t an option.

Our Dr. Jaffer Ajani co-led the clinical trial, which led to the practice-changing approval: bit.ly/3a50l1W #EndCancer

thumb_up_off_alt33

chat_bubble_outline1

repeat8

shareShare

Jaffer Ajani

@jafferajanimd

3 years ago

Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment gut.bmj.com/content/early/…

thumb_up_off_alt10

chat_bubble_outline2

repeat3

shareShare

Jaffer Ajani

Gate.io

MD Anderson Cancer Center

Jaffer Ajani